Morgan Stanley’s The Valens Company, Inc. Common Shares VLNS Stock Holding History

Morgan Stanley’s Portfolio VLNS Stock Details VLNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-202,861	Closed	-$134K	–	7992
2022 Q4	$134K	Buy	202,861 +119,582	+144%	+$90.9K	﹤0.01%	5846
2022 Q3	$56K	Buy	83,279 +79,247	+1,965%	+$64K	﹤0.01%	6362
2022 Q2	$2K	Buy	4,032 +591	+17%	+$539	﹤0.01%	7635
2022 Q1	$6K	Sell	3,441 -9,595	-74%	-$20.5K	﹤0.01%	7558
2021 Q4	$32K	Buy	+13,036	New	+$35.6K	﹤0.01%	7016

Morgan Stanley's VLNS Position: Q1 2023 in Review

Morgan Stanley sold out of The Valens Company, Inc. Common Shares (VLNS) in Q1 2023, closing a stake of 202,861 shares — an estimated $134K sold.

Morgan Stanley first reported a position in VLNS in Q4 2021 and held it in 5 quarters. The position peaked at $134K in Q4 2022. 0 funds tracked by Wall St. Rank hold VLNS as of Q1 2023.

Morgan Stanley reported no remaining The Valens Company, Inc. Common Shares position as of Q1 2023 after selling out during the quarter.
Morgan Stanley sold 202,861 The Valens Company, Inc. Common Shares shares in Q1 2023, an estimated $134K.
Morgan Stanley first reported a position in The Valens Company, Inc. Common Shares in Q4 2021 and held it in 5 quarters.
Morgan Stanley's The Valens Company, Inc. Common Shares position peaked at $134K in Q4 2022.
0 funds tracked by Wall St. Rank held The Valens Company, Inc. Common Shares as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.